James Madison University is a public research university in Harrisonburg, Virginia. Founded in 1908 as the State Normal and Industrial School for Women at Harrisonburg, the institution was renamed Madison College in 1938 in honor of President James Madison and then James Madison University in 1977.

During the past decade, James Madison University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "James Madison University" #1 sponsor was "Canopy Growth Corporation" with 1 trials, followed by "Emory University" with 1 trials sponsored, "James Madison University" with 1 trials sponsored, "Shirley Ryan AbilityLab" with 1 trials sponsored and "University of Virginia" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "James Madison University" #1 collaborator was "James Madison University" with 3 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Dystonia Study Group" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Office of Rare Diseases (ORD)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "James Madison University" are "Anxiety" (1 trials), "Aphasia" (1 trials), "Brain Injury" (1 trials), "Dystonia" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "James Madison University" in a lesser frequency.

Most popular intervention types in "James Madison University" are "Behavioral" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CHI-804" (1 trials), "CHI-907" (1 trials), "Dysphagia retraining with device" (1 trials), "HandWriting Intervention (ORLA+WTG)" (1 trials) and "Riboflavin 400mg daily" (1 trials). Other intervention names were less common.

The vast majority of trials in "James Madison University" are 5 trials for "All" genders.

Currently, there are NaN active trials in "James Madison University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in James Madison University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in James Madison University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".